Selected article for: "CAP severity and pediatric CAP severity"

Author: El Gendy, Fady M.; El-Mekkawy, Muhammad Said; El-Naidany, Sherin Sobhy; El-torgoman, Shimaa Tarek
Title: The role of Tumor necrosis factor alpha −308 G>A promoter polymorphism in pediatric community acquired pneumonia
  • Cord-id: afs9eb40
  • Document date: 2020_2_10
  • ID: afs9eb40
    Snippet: BACKGROUND: Tumor necrosis factor alpha (TNF-α) −308 G>A promoter polymorphism might be associated with excessive production of the proinflammatory cytokine TNF-α, modulating host response to pulmonary infections. Our objective was to evaluate the association of TNF-α gene −308 G>A polymorphism with susceptibility to, and severity of, community-acquired pneumonia (CAP). RESULTS: This was a cross-sectional study including 45 Egyptian children hospitalized for CAP in addition to 45 healthy
    Document: BACKGROUND: Tumor necrosis factor alpha (TNF-α) −308 G>A promoter polymorphism might be associated with excessive production of the proinflammatory cytokine TNF-α, modulating host response to pulmonary infections. Our objective was to evaluate the association of TNF-α gene −308 G>A polymorphism with susceptibility to, and severity of, community-acquired pneumonia (CAP). RESULTS: This was a cross-sectional study including 45 Egyptian children hospitalized for CAP in addition to 45 healthy children who served as a control group. Pneumonia severity was assessed on admission by the World Health Organization (WHO) guidelines; Pediatric Respiratory Severity Score (PRESS) score; Predisposition, Infection, Response and Organ failure (PIROm) score; and Respiratory Index of Severity in Children (RISC) score. Genotyping of TNF-α polymorphism was performed to all individuals by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Patients were monitored till hospital discharge. Frequency of AG genotype was lower among patients compared with control [odds ratio (OR) and 95% confidence interval (CI) = 0.13 (0.03–0.63); p = 0.012]. Prevalence of genotypes AA+AG was lower among patients compared with controls [OR and 95% CI = 0.34 (0.12–0.99); p = 0,048]. The “A” allele prevalence was higher among controls, but no significant association was found with CAP [OR and 95% CI = 0.58 (0.25–1.35); p = 0.21]. When PRESS score was used to classify patients into “severe pneumonia” and “non-severe pneumonia,” no significant association of any of the alleles or genotypes with CAP severity was found. CONCLUSION: TNF-α −308 G>A polymorphism confers protection from pediatric CAP but is not associated with indicators of CAP severity. Larger studies are needed to confirm these findings in pediatric patients from different ethnicities.

    Search related documents:
    Co phrase search for related documents
    • absence presence and additional factor: 1
    • absence presence and adhesion molecule: 1, 2, 3, 4
    • absence presence and adhesion molecule expression: 1
    • additional factor and adhesion molecule: 1
    • additional factor and adhesion molecule expression: 1